Abstract. Tanshinone IIA (Tan-IIA) was isolated from Salviae Miltiorrhizae Radix. Our previous studies showed that Tan-IIA induced apoptosis in human colon cancer colo 205 cells, but the molecular mechanisms of the effect of Tan-IIA on human colon cancer were not clearly elucidated. The protein expression of ErbB-2 was up-regulated and activated in human and experimental colon cancers. In the present study, the effects of Tan-IIA on the protein expression of ErbB-2 in colo 205 cells were investigated. In vitro, colo 205 cells were treated with various concentrations of Tan-IIA (1, 2 and 5 μg/ ml) for 24 h, and the protein expression of TNF-α, ErbB-2 and caspase-3 was assayed by Western blotting. For the in vivo studies, male SCID mice were xenografted with colo 205 cells, and from day 10, Tan IIA (20 mg/kg/day, dissolved in corn oil) was administered by oral feeding for 30 days. As a control, mice with xenografted tumors were separately treated with corn oil (0.1 ml/10 g body weight). Expression of TNF-α, ErbB-2 and caspase-3 proteins was measured by Western blot analysis. Our results showed that Tan-IIA down-regulated the protein expression of ErbB-2 and up-regulated TNF-α and caspase-3 in colo 205 cells in vitro. In a colo 205 xenograft model, treatment with Tan-IIA caused up-regulation of TNF-α, caspase-3 and down-regulation of ErbB-2 protein expression as compared to the controls. Based on these observations, one possible molecular mechanisms by which Tan-IIA inhibits the proliferation of colo 205 cells is through the downregulation of ErbB-2 protein expression and the upregulation of the protein expression of TNF-α and caspase-3.
Introduction
Danshen (Salviae miltiorrhizae Radix) is widely prescribed in traditional Chinese medicine to treat cardiovascular diseases and dysmenorrhea (1, 2) . Tanshinone IIA (Tan-IIA), an extract from Danshen (3, 4) , possesses anti-inflammatory activities (5, 6) , anti-oxidant properties (7) (8) (9) and anti-cancer activity in multiple types of human cancer cells (10) (11) (12) . Our previous study showed that Tan-IIA has the ability to induce cell growth reduction and apoptosis in human colon cancer colo 205 cells, but the molecular mechanisms were not clearly elucidated. Tumor necrosis factor α (TNF-α), a cytotoxic factor, is produced by macrophages (13) . TNF receptor type 1, a cytokine receptor, is expressed in most tissues, and can be activated by binding to TNF-α, forming the death inducing signaling complex. This results in the recruitment of caspases and the induction of its autoproteolytic activation and subsequent cleaving of effector caspase-3 leading to cell apoptosis (14) . It is well documented that ErbB-2 (erythroblastosis oncogene B; HER-2/neu) is one of the transmembrane tyrosine kinase receptor that is overexpressed in human colorectal adenocarcinomas and serves as an independent prognostic factor (15) (16) (17) . This knowledge can be applied to develop new chemotherapeutic medication which blocks the expression of ErbB-2 in colorectal cancer patients. The present study was designed to identify the effects of Tan-IIA on the protein expression of ErbB-2 in colon cancer colo 205 cells in vivo and in vitro. 3 tissue culture flasks and grown at 37˚C in a humidified atmosphere of 5% CO 2 and 95% air in RPMI-1640 medium, containing 10% heat-inactivated fetal bovine serum (FBS), 2% penicillinstreptomycin (10,000 U/ml penicillin; 10 mg/ml streptomycin), 1% HEPES, 1% sodium pyruvate and 1% glutamine.
Materials and methods

Chemicals
The effects of Tan-IIA on the protein expression of TNF-α, ErbB-2, caspase-3 and ß-actin in colo 205 cells in vitro
Protein preparation. For protein extraction, colo 205 cells (2x10 6 ) were initially seeded on 10-cm cultured dishes and treated with Tan-IIA at the concentrations of 0, 1, 2 and 5 μg/ ml for 24 h before cells were harvested by centrifugation. Proteins were extracted as previously described (18) . Briefly, cell pellets were resuspended in modified RIPA buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% Nonidet p-40, 0.25% sodium deoxycholate, 1 mM EGTA, 1 mM DTT, 1 mM PMSF, 1 mM sodium orthovanadate, 1 mM sodium fluoride, 5 μg/ml aprotinin, 5 μg/ml leupeptin and 5 μg/ml antipain) for 30 min at 4˚C. Lysates were immediately centrifuged at 13,000 x g for 20 min at 4˚C, and the supernatant was collected, aliquated (50 g/tube) and stored at -80˚C until assay. The extracted protein concentrations were measured using the Bradford method (19).
Western blotting. All protein samples were separated by 12% sodium dodecylsulfate polyacrylamide gel electrophoresis (SDS-PAGE) (Bio-Rad Life Science Products, Hercules, CA, USA) as previously described (18) . The SDSseparated proteins were followed by equilibration in transfer buffer (50 mM Tris, pH 9.0, 40 mM glycine, 0.375% SDS and 20% methanol) and were transferred onto an Immobilon-P membrane (Millipore Corp., Bedford, MA, USA). The membranes were incubated with 5% nonfat dry milk in Trisbuffered saline containing 0.05% Tween-20 for 1 h. The membranes were then washed and incubated with appropriate dilutions of specific antibodies such as TNF-α, ErbB-2, caspase-3 and ß-actin (Upstate, Lake Placid, NY, USA) at 4˚C overnight. After incubation with anti-mouse peroxidaseconjugated antibody (Santa Cruz, CA, USA), the immunoreactive bands were visualized with an enhanced chemiluminescence (ECL, Amerham Pharmacia Biotech) detection kit. The detection of ß-actin was used as an internal control in all of the data for Western blotting.
The effects of Tan-IIA on the protein expression of TNF-α, ErbB-2, caspase-3 and ß-actin in colo 205 cell xenograft tumors. Three-week-old male nude SCID mice were xenografted with colon cancer colo 205 cells (2x10 6 /0.2 ml) and maintained in a pathogen-free environment (Laboratory Animal Center of Tzu Chi University, Hualien, Taiwan, R.O.C.). From day 10, Tan IIA (20 mg/kg/day, 0.2 mg Tan IIA dissolved in 0.1 ml corn oil) was administered by oral feeding for 30 days (n=5 mice). The mice were subsequently sacrificed by CO 2 inhalation. As a control, mice (n=4) bearing xenografted tumors were separately treated with corn oil (0.1 ml/10 g body weight). The xenograft tumors were dissected, and protein was extracted for Western blot analysis. The protein expression of TNF-α, ErbB-2 and caspase-3 was 
Results
The effects of Tan-IIA on the protein expression of TNF-α, ErbB-2, caspase-3 and ß-actin in colo 205 cells in vitro.
The colo 205 cells (2x10 6 /ml) were treated with various concentrations (0, 1, 2 and 5 μg/ml) of Tan-IIA for 24 h, and total protein was prepared and determined as described in Materials and methods. Colo 205 cells were harvested in the presence of Tan-IIA for Western blotting. The results indicated that Tan-IIA increased the expression of TNF-α at the concentrations of 2 and 5 μg/ml for 24 h (Fig. 1 ) and the expression of caspase-3 at the concentrations of 1, 2 and 5 μg/ml for 24 h (Fig. 2) . The protein expression of ErbB-2 in colo 205 cells was significantly decreased when treated with Tan-IIA at the concentration of 5 μg/ml for 24 h (Fig. 3) . (Fig. 4) and caspase-3 (Fig. 5) and the down-regulation of ErbB-2 protein expression (Fig. 6 ) when compared to the controls.
Discussion
Our previous studies demonstrated that Tan-IIA inhibited proliferation and induced apoptosis in human colon cancer colo 205 cells in a dose-dependent manner (20) . In the present study, the results showed that Tan-IIA treatment increased the TNF-α and caspase-3 levels in colo 205 cells in vivo and in vitro. It is well documented that once the TNF-α receptor is ligated, the receptor forms the death-inducing signaling complex, which activates the downstream caspase-3 cascade and consequent apoptosis (14) . This process is provoked by external stimuli that bind membrane receptors and ultimately activate caspases resulting in cell death (21) . Therefore, Tan-IIA induces apoptosis in colon cancer cells by activating the death receptor-mediated pathways. It is well documented that inhibition of the ErbB-2 activity results in an increased propensity for apoptosis and reduced malignancy in vivo (22, 23) . Our results demonstrate that Tan-IIA down-regulates ErbB-2 protein expression in colo 205 cells in vivo and in vitro. This is the first study to demonstrate that Tan-IIA downregulates ErbB-2 and up-regulates TNF-α protein expression in human colon cancer cells suggesting that Tan-IIA may have therapeutic potential for human colon cancer. 
